{"id":"W2748400555","doi":"10.1056/nejmoa1707914","title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9109,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Canakinumab; Medicine; Placebo; Myocardial infarction; Hazard ratio; Internal medicine; Confidence interval; Randomized controlled trial; Clinical endpoint; C-reactive protein; Surgery; Gastroenterology; Inflammation; Disease; Pathology; Anakinra","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}